Implantable medical lead with shield
By using an asymmetrically shaped expandable shield in the implanted medical lead system, the electric field is prevented from conducting the electric field to the heart, solving the problem that exovascular implanted medical leads requires higher energy and electric field to guide away from the heart, achieving more Low energy levels of heart capture and extend ICD life.
Patent Information
- Application Number
- CN202380026366.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-11
- Filing Date
- 2023-03-10
- Publication Date
- 2024-11-19
AI Technical Summary
Implanted medical leads require higher energy levels to capture and defibrillate the heart when used extravascularly, and conventional pacing electrodes cause electric fields to direct away from the heart, stimulating extracardiac tissue, and increasing the risk of unanticipated tissue stimulation.
Using an implantable medical lead system including an expandable shield, the shield is arranged on the outer surface of the pacing electrode, with an asymmetric shape, which prevents the electric field from conducting in the heart, thereby reducing the possibility of stimulation of extracardiac tissue and allowing for a lower The pacing pulse at the energy level captures the heart.
It effectively reduces the possibility of unanticipated tissue stimulation, reduces the power consumption of ICD, extends the service life of the equipment, and improves the electric field guidance efficiency to the heart.
Smart Images

Figure CN118984726A_ABST
Abstract
Description
[0001] This application claims priority to U.S. Provisional Patent Application No. 63 / 269,191, filed on March 11, 2022, entitled “IMPLANTABLE MEDICAL LEAD WITH SHIELD,” the entire contents of which are incorporated herein by reference. Technical Field
[0002] The present application relates to implantable medical leads, and more particularly to implantable medical leads having one or more features to reduce the likelihood of stimulation of unintended tissue. Background Art
[0003] Malignant tachyarrhythmias, such as ventricular fibrillation (VF), are uncoordinated contractions of the myocardium of the ventricles in the heart and are the most common arrhythmias in cardiac arrest patients. If such arrhythmias persist for more than a few seconds, cardiogenic shock and cessation of effective blood circulation may result. As a result, sudden cardiac death (SCD) may occur within minutes.
[0004] In patients with a high risk of VF, the use of implantable systems, such as implantable cardioverter defibrillator (ICD) systems, has been shown to be beneficial in preventing SCD. Implantable systems, such as pacemakers with or without cardioversion or defibrillation capabilities, can also treat other cardiac dysfunctions, such as bradycardia and heart failure. Such implantable systems may include an electrical device configured to deliver treatment via electrodes. Treatment may include electric shock and / or anti-tachycardia pacing (ATP). Implantable systems may also be configured to deliver cardiac pacing, for example, to treat bradyarrhythmias or for cardiac resynchronization therapy (CRT).
[0005] The implantable system may include one or more implantable medical leads. The distal portion of the implantable medical lead may include one or more electrodes and may be positioned at a target location within the patient's body for delivering electrical therapy and / or electrical sensing via the electrodes. The proximal end of the lead may be coupled to the implantable system. The implantable system may also include one or more housing electrodes, sometimes referred to as can electrodes, for delivering therapy and / or sensing.
[0006] Due to the inherent surgical risks of attaching and replacing implantable medical leads directly in or on the heart, subcutaneous implantable systems have been designed in which the implantable system and leads are located under the skin outside the thorax. It has also been proposed that the distal portion of the lead of the implantable system can be implanted in the thorax, but not in contact with the heart, for example, under the sternum. Additionally, it has been proposed to implant the distal portion of the lead of the implantable system in an extracardiac vessel within the thorax, such as the internal thoracic vein (ITV), intercostal veins, superior epigastric vein or azygos vein, hemiazygos vein and accessory hemiazygos vein.
[0007] Implantable medical leads are also used to deliver therapy to tissues other than the heart. Implantable medical leads can be used to position one or more electrodes in or near a target nerve, muscle, or organ to deliver electrical stimulation to such tissue. As an example, an implantable medical lead can be positioned in the epidural space to deliver spinal cord stimulation, or positioned near other nerves such as the pelvic nerves or renal nerves to deliver neurostimulation to the nerves. Summary of the invention
[0008] Compared to electrodes on or in the heart, using electrodes of extravascular leads to deliver pacing pulses or defibrillation may require higher energy levels to capture and / or defibrillate the heart. In addition, conventional pacing electrodes placed outside the blood vessels can direct most of the electric field generated by the pacing pulse away from the heart. The electric field directed away from the heart can stimulate extracardiac tissues such as the phrenic nerve, nerve endings in the intercostal area, or other sensory or motor nerves. These problems can similarly occur when electrodes are implanted in extracardiac vessels within the thorax such as the ITV, intercostal veins, superior epigastric veins, or the azygos, hemiazygos, and para-hemiazygos veins, or when electrodes are implanted in other extracardiac locations.
[0009] The present disclosure describes implantable medical leads and implantable systems utilizing the leads, such as ICD systems. More specifically, the present disclosure describes a system including an implantable medical lead and an expandable shielding member, the expandable shielding member being configured to block an electric field from the implantable medical lead in a direction from the implantable medical lead and the heart (e.g., a forward direction), for example, to block or reduce the electric field. In this way, the shielding member can reduce the likelihood of unintended stimulation of patient tissue. Additionally, the shielding member can be delivered via a delivery tool. For example, the shielding member can be unexpanded, for example, compressed, shrunk, etc., so as to be compatible with a cavity of a delivery tool such as an introducer, and delivered to a desired location in the patient's body. The configuration of the shielding member can further improve the removal of the shielding member and / or the implantable medical lead. For example, the expandable and compressible shielding member can be compressed, shrunk, etc., so as to be removable by an introducer tool. In some examples, the shield can be compressed, deflated, etc. to release from the patient's tissue to facilitate removal of the implanted medical lead, or attached to the implanted medical lead to reduce and / or prevent tissue ingrowth, and thereby improve removal of the implanted medical lead and the shield. In addition, the shield can direct the electric field toward the heart, thereby allowing a lower energy level electric field to capture the heart than would be required without the shield. Lower energy pacing pulses can also reduce the likelihood that pacing pulses delivered via the pacing electrodes will stimulate extracardiac tissue, and can result in less power consumption by the ICD, and thus extend the useful life of the ICD.
[0010] Although described herein primarily in the context of an ICD system, various aspects of the technology disclosed herein may be applied to implantable systems other than ICD systems, including but not limited to bradycardia or CRT pacemaker systems. Thus, an implantable medical lead having one or more shields may be used in contexts other than ICD systems, including both cardiac and non-cardiac. As an example, an implantable medical lead having a shield over a portion of an electrode surface may be used with an extracardiac pacemaker system that does not have defibrillation capability. As another example, an implantable medical lead having a shield over a portion of an electrode surface may prevent the electric field generated by the electrode from delivering neural stimulation in a direction away from the target nerve. In this way, the shield may direct the neural stimulation to the intended tissue and reduce the likelihood that the neural stimulation will stimulate unintended tissue.
[0011] In one example, the present disclosure describes an implantable medical lead comprising: a first defibrillation electrode and a second defibrillation electrode, the first defibrillation electrode and the second defibrillation electrode being configured to deliver a first electrical therapy; a pacing electrode, the pacing electrode being longitudinally disposed between the first defibrillation electrode and the second defibrillation electrode, the pacing electrode being configured to deliver a second electrical therapy comprising a pacing pulse; and a shield, the shield being disposed over a portion of an outer surface of the pacing electrode and extending laterally away from the pacing electrode, wherein the shield comprises an asymmetric shape about a longitudinal axis of the shield, wherein the shield is configured to obstruct an electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from a heart of a patient.
[0012] In another example, the present disclosure describes a method comprising: positioning an implantable medical lead at an implantation location within a patient's body, wherein the implantable medical lead comprises: a first defibrillation electrode and a second defibrillation electrode, the first defibrillation electrode and the second defibrillation electrode being configured to deliver anti-tachyarrhythmia shocks; a pacing electrode, the pacing electrode being longitudinally disposed between the first defibrillation electrode and the second defibrillation electrode, the pacing electrode being configured to deliver pacing pulses that generate an electric field near the pacing electrode; and a shield, the shield being configured to be disposed over at least a portion of an outer surface of the pacing electrode and extending laterally away from the pacing electrode in an expanded configuration, wherein the shield comprises an asymmetric shape around a longitudinal axis of the shield in the expanded configuration, wherein the shield is configured to obstruct an electric field of at least one of a first electrical therapy and a second electrical therapy in a direction away from the patient's heart in the expanded configuration; and expanding the shield from the first shape to the asymmetric shape in the expanded configuration via expanding the implantable medical lead.
[0013] In another example, the present disclosure describes a system comprising: an implantable medical lead comprising: a first defibrillation electrode and a second defibrillation electrode, the first defibrillation electrode and the second defibrillation electrode being configured to deliver a first electrical therapy; a pacing electrode, the pacing electrode being longitudinally disposed between the first defibrillation electrode and the second defibrillation electrode, the pacing electrode being configured to deliver a second electrical therapy comprising a pacing pulse; and a shield comprising a substantially flat and single-layer biocompatible material configured to be attached to the implantable medical lead and being in a first shape in an undeployed configuration, wherein the shield is configured to be compatible with a delivery tool in the first shape, wherein the shield is configured to be asymmetrically shaped about a longitudinal axis of the shield and is disposed above a portion of an outer surface of the pacing electrode and extends laterally away from the pacing electrode in a deployed configuration, wherein the asymmetrical shape, wherein the shield is configured to obstruct an electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from the patient's heart in the deployed configuration.
[0014] In another example, the present disclosure describes an implantable medical lead comprising: a first defibrillation electrode and a second defibrillation electrode, the first defibrillation electrode and the second defibrillation electrode configured to deliver a first electrical therapy; a pacing electrode, the pacing electrode longitudinally disposed between the first defibrillation electrode and the second defibrillation electrode, the pacing electrode configured to deliver pacing pulses that generate an electric field near the pacing electrode; and an inflatable shield disposed at least over a portion of an outer surface of the pacing electrode, wherein the inflatable shield is configured to extend laterally away from the pacing electrode when inflated, wherein the inflatable shield is configured to obstruct the electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from the patient's heart.
[0015] In another example, the present disclosure describes a method comprising: positioning an implantable medical lead at an implantation location within a patient, wherein the implantable medical lead comprises: a first defibrillation electrode and a second defibrillation electrode, the first defibrillation electrode and the second defibrillation electrode being configured to deliver a first electrical therapy; a pacing electrode, the pacing electrode being longitudinally disposed between the first defibrillation electrode and the second defibrillation electrode, the pacing electrode being configured to deliver pacing pulses that generate an electric field near the pacing electrode; and an inflatable shield, the inflatable shield being disposed at least over a portion of an outer surface of the pacing electrode, wherein the inflatable shield is configured to extend laterally away from the pacing electrode in an inflated shape when inflated, wherein the inflatable shield is configured to obstruct an electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from the patient's heart; and inflating the inflatable shield from a deflated shape to an inflated shape.
[0016] In another example, the present disclosure describes a system comprising: an implantable medical lead comprising: a first defibrillation electrode and a second defibrillation electrode, the first defibrillation electrode and the second defibrillation electrode being configured to deliver a first electrical therapy; a pacing electrode, the pacing electrode being disposed between the first defibrillation electrode and the second defibrillation electrode, the pacing electrode being configured to deliver a second electrical therapy comprising a pacing pulse; and a lead body, the lead body defining a cavity, the cavity being configured to guide a needle; an inflatable shielding member disposed at least over a portion of an outer surface of the pacing electrode, wherein the inflatable shielding member is configured to extend laterally away from the pacing electrode when inflated, wherein the inflatable shielding member is configured to obstruct an electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from a heart of a patient; and a diaphragm, the diaphragm being between the cavity and the inflatable shielding member, the diaphragm being configured to form a seal around the needle, wherein the needle is configured to provide at least one of a gas or a liquid to inflate the inflatable shielding member.
[0017] This summary is intended to provide an overview of the subject matter described in this disclosure. It is not intended to provide an exclusive or exhaustive explanation of the systems, devices, and methods described in detail in the drawings and the following description. Further details of one or more examples are set forth in the following drawings and description. Other features, objects, and advantages will be apparent from the description and drawings and from the statements provided below. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1A Anterior view of a patient with an intrathoracic extracardiovascular ICD system.
[0019] Figure 1B A side view of a patient with an intrathoracic extracardiac ICD system.
[0020] Figure 1C Transverse view of a patient with an intrathoracic extracardiovascular ICD system.
[0021] Figure 2A is a conceptual diagram illustrating a front view of a distal portion of an example implantable medical lead and an example shield in a deployed configuration.
[0022] Figure 2B is an example of Figure 2A Conceptual illustration of a side view of a distal portion and shield of an example implantable medical lead in an expanded configuration.
[0023] Figure 3A is an example in an unexpanded configuration Figure 2A Conceptual illustration of a front view of a distal portion of an example implantable medical lead and an example shield.
[0024] Figure 3B is an example of Figure 3A Conceptual illustration of a side view of a distal portion and shield of an example implantable medical lead in an undeployed configuration.
[0025] Figure 4 is a conceptual cross-sectional view of an electrode of an example implantable medical lead and an example shield.
[0026] Figure 5A is a conceptual diagram illustrating a front view of another example implantable medical lead distal portion and another example shield in a deployed configuration.
[0027] Figure 5B is a conceptual diagram illustrating a front view of another example implantable medical lead distal portion and another example shield in a deployed configuration.
[0028] Figure 6 is a conceptual diagram illustrating a front view of another example implantable medical lead distal portion and another example shield in a deployed configuration.
[0029] Figure 7 is a conceptual diagram illustrating a front view of another example implantable medical lead distal portion and another example shield in a deployed configuration.
[0030] Figure 8 is a conceptual diagram illustrating a distal portion of another example implantable medical lead in a deployed configuration and a side view of another example shield.
[0031] Fig. 9 is a conceptual diagram illustrating a front view of another example distal portion of another implantable medical lead and another example shield in a deployed configuration.
[0032] Fig.10 is a flow chart illustrating an example technique for implanting an implantable medical lead that includes a shield.
[0033] Fig.11 is a flow chart illustrating an example technique for implanting an implantable medical lead including an inflatable shield.
[0034] Fig.12 is a functional block diagram of an example configuration of electronic components of an example ICD.
[0035] FIG. 13A to FIG. 13J are conceptual diagrams illustrating front views of distal portions of various example implantable medical leads, each having various shapes, and various example shields, each having various shapes, each in a deployed configuration.
[0036] Fig.14 is a conceptual diagram illustrating a front view of another example distal portion of an implantable medical lead and another example shield including a taper and in a deployed configuration. DETAILED DESCRIPTION
[0037] As used herein, relational terms such as "first" and "second", "above" and "below", "front" and "back", etc. may be used solely to distinguish one entity or element from another entity or element without necessarily requiring or implying any physical or logical relationship or order between such entities or elements.
[0038] Referring now to the drawings in which like reference designators refer to like elements, Figures 1A to 1C A conceptual diagram illustrating various views of an example cardiovascular implantable cardioverter-defibrillator (ICD) system 8 is shown in FIG. The ICD system 8 includes an ICD 9 connected to implantable medical leads 10. Figure 1A is a front view of a patient 12 implanted with an extracardiovascular ICD system 8 . Figure 1B is a side view of a patient 12 implanted with an extracardiovascular ICD system 8 . Figure 1C is a lateral view of a patient 12 implanted with an extracardiovascular ICD system 8 .
[0039] The ICD 9 may include an outer shell that forms an airtight seal that protects the components of the ICD 9. The outer shell of the ICD 9 may be formed of a conductive material, such as titanium or a titanium alloy, which may be used as an outer shell electrode (sometimes referred to as a can electrode). In some embodiments, the ICD 9 may be formed to have or may include multiple electrodes on the outer shell. The ICD 9 may also include a connector assembly (also referred to as a connector block or plug) that includes electrical feedthroughs through which electrical connections are made between the conductors of the leads 10 and the electronic components included in the outer shell of the ICD 9. As will be described in further detail herein, the outer shell may accommodate one or more processors, memories, transmitters, receivers, sensors, sensing circuits, treatment circuits, power supplies, and other suitable components. The outer shell is configured to be implanted in a patient, such as a patient 12.
[0040] ICD 9 is implanted outside the left thorax of the patient, for example, under the skin and outside the chest cavity (subcutaneous or submuscular). In some cases, ICD 9 may be implanted between the left posterior axillary line and the left anterior axillary line of the patient. However, as described later, ICD 9 may be implanted in other extrathoracic locations of the patient.
[0041] Lead 10 may include an elongated lead body 13 having a distal portion 16 sized to be implanted in an extracardiac location near the heart, such as within the thorax, e.g. Figures 1A to 1CFor example, lead 10 may extend from ICD 9 toward the center of the patient's torso, e.g., toward the patient's xiphoid process 23, under the skin and outside the chest (e.g., subcutaneously or submuscularly) to outside the chest. At a location near xiphoid process 23, lead body 13 may be bent or otherwise rotated upward and extended. The bend may be preformed and / or lead body 13 may be flexible to facilitate the bend. Figures 1A to 1C In the example illustrated in , the lead body 13 extends upward within the thorax below the sternum in a direction substantially parallel to the sternum.
[0042] In one example, the distal portion 16 of the lead 10 can be located in a substernal position such that the distal portion 16 of the lead 10 extends substantially upward along the posterior side of the sternum within the anterior mediastinum 36. The anterior mediastinum 36 can be considered to be bounded laterally by the pleura 39, posteriorly by the pericardium 38, and anteriorly by the sternum 22. In some cases, the anterior wall of the anterior mediastinum 36 can also be formed by the transverse thoracic muscle and one or more costal cartilages. The anterior mediastinum 36 includes a large amount of loose connective tissue (such as cellulite), adipose tissue, some lymphatic vessels, lymph glands, substernal muscle tissue (e.g., transverse chest muscle), thymic body, branches of the internal thoracic artery, and the ITV.
[0043] In another example, the lead body 13 may extend superiorly outside the thorax (rather than into the thorax), for example, subcutaneously or submuscularly above the thorax / sternum. The lead 10 may be implanted at other locations, such as above the sternum, offset to the right of the sternum, angled laterally from the proximal or distal end of the sternum, etc. In other examples, the lead 10 may be implanted in an extracardiac vessel within the thorax, such as the ITV, intercostal veins, superior epigastric veins, or the azygos, hemiazygos, para-hemiazygos, or between the heart and lungs and within the pleural cavity. In some examples, the orientation of the distal portion 16 of the lead 10 may be different from that of the distal portion 16 of the lead 10. Figures 1A to 1C , such as orthogonal to or otherwise transverse to the sternum 22 and / or below the heart 26. In such examples, the distal portion 16 of the lead 10 can be at least partially within the anterior mediastinum 36.
[0044] The lead body 13 may have a generally tubular or cylindrical shape and may define a diameter of approximately 3-9 French (Fr). However, lead bodies less than 3 Fr and greater than 9 Fr may also be utilized. In another configuration, the lead body 13 may have a flat, ribbon-like or paddle-like shape along at least a portion of the length of the lead body 13, with a solid woven filament or metal mesh structure. In such examples, the width across the lead body 13 may be between 1 mm and 3.5 mm. Other lead body designs may be used without departing from the scope of the present application.
[0045] The lead body 13 may be formed of a non-conductive material including silicone, polyurethane, fluoropolymer, mixtures thereof, and other suitable materials, and shaped to form one or more cavities (not shown), however, the technology is not limited to such configurations. The distal portion 16 may be manufactured to be biased in a desired configuration, or alternatively, may be manipulated by a user into a desired configuration. For example, the distal portion 16 may be constructed of a ductile material so that the user can manipulate the distal portion into a desired configuration that remains unchanged until manipulated into a different configuration.
[0046] The lead body 13 may include a proximal end 14 and a distal portion 16, which includes an electrode configured to deliver electrical energy to the heart or sense electrical signals of the heart. The distal portion 16 can be anchored to a desired location in the patient's body, such as under the sternum or subcutaneously, by, for example, suturing the distal portion 16 to the patient's muscle tissue, tissue or bone at the xiphoid process entry site. In some examples, the distal portion 16 can be anchored to the patient or by using rigid tines, prongs, barbs, clips, screws and / or other protruding elements or flanges, discs, compliant tines, flaps, porous structures such as mesh elements and metal or non-metal stents that promote tissue growth to engage, bioadhesive surfaces and / or any other non-piercing elements.
[0047] The lead body 13 may define a substantially linear portion 20 ( Figure 1A ).like Figure 1A As shown, at least a portion of the distal portion 16 can define a wavy configuration distal to the substantially linear portion 20. In particular, the distal portion 16 can define a wavy pattern, such as a sawtooth, zigzag, sinusoidal, serpentine, or other pattern, as it extends toward the distal end of the lead 10. In other configurations, the lead body 13 may not have a substantially linear portion 20 as it extends upward, but may begin the wavy configuration immediately after the bend.
[0048] Distal portion 16 includes one or more defibrillation electrodes configured to deliver a first electrical therapy (such as an anti-tachyarrhythmia shock, e.g., a cardioversion / defibrillation shock) to heart 26 of patient 12. In some examples, distal portion 16 includes a plurality of defibrillation electrodes spaced a distance apart from one another along the length of distal portion 16. Figures 1A to 1C In the illustrated example, the distal portion 16 includes two defibrillation electrodes 28a and 28b (collectively referred to as “defibrillation electrodes 28 ”).
[0049] The defibrillation electrodes 28 may be disposed around or within the lead body 13 of the distal portion 16, or alternatively, may be embedded within the wall of the lead body 13. In one configuration, the defibrillation electrodes 28 may be coil electrodes formed of a conductor. The conductor may be formed of one or more conductive polymers, ceramics, metal-polymer composites, semiconductors, metals, or metal alloys, including but not limited to one of platinum, tantalum, titanium, niobium, zirconium, ruthenium, indium, gold, palladium, iron, zinc, silver, nickel, aluminum, molybdenum, stainless steel, MP35N, carbon, copper, polyaniline, polypyrrole, and other polymer combinations. In another configuration, each of the defibrillation electrodes 28 may be a flat ribbon electrode, a paddle electrode, a braided or woven electrode, a mesh electrode, a directional electrode, a patch electrode, or another type of electrode configured to deliver a cardioversion / defibrillation shock to the heart 26 of the patient 12.
[0050] In one configuration, the defibrillation electrodes 28 are spaced approximately 0.25 cm-4.5 cm apart, and in some cases 1 cm-3 cm apart from each other. In another configuration, the defibrillation electrodes 28 are spaced approximately 0.25 cm-1.5 cm apart from each other. In yet another configuration, the defibrillation electrodes 28 are spaced approximately 1.5 cm-4.5 cm apart from each other.
[0051] exist Figures 1A to 1C In the illustrated configuration, the defibrillation electrodes 28 span a majority of the distal portion 16. Each of the defibrillation electrodes 28 may have a length between about 1 cm-10 cm, a length between about 2 cm-6 cm, or a length between about 3 cm-5 cm. However, according to the techniques of the present disclosure, lengths greater than 10 cm and less than 1 cm may be utilized. The total length of the defibrillation electrodes on the distal portion 16, such as the length of the two defibrillation electrodes 28 combined, may vary according to a number of variables. In one example, the total length may be between about 5 cm-10 cm. However, in other embodiments, the defibrillation electrodes 28 may have a total length less than 5 cm and greater than 10 cm. In some cases, the defibrillation electrodes 28 may have substantially the same length, or alternatively, different lengths.
[0052] The defibrillation electrodes 28 may be electrically connected to one or more conductors that may be disposed in the body wall of the lead body 13 or in one or more insulating cavities (not shown) defined by the lead body 13. In an example configuration, each of the defibrillation electrodes 28 is connected to a common conductor so that a voltage may be applied to all of the defibrillation electrodes 28 simultaneously to deliver an anti-tachyarrhythmia shock to the heart 26. In other configurations, the defibrillation electrodes 28 may be attached to separate conductors so that each defibrillation electrode 28 may have a voltage applied to it independently of the other defibrillation electrodes 28. In such a case, the ICD 9 or lead 10 may include one or more switches or other mechanisms to electrically connect the defibrillation electrodes together to serve as common polarity electrodes so that, in addition to being able to apply voltage independently, a voltage may be applied to all of the defibrillation electrodes 28 simultaneously.
[0053] The distal portion 16 may also include one or more pacing and / or sensing electrodes configured to deliver a second electrical therapy (such as pacing pulses) to the heart 26 and / or sense electrical activity of the heart 26. Such electrodes may be referred to as pacing electrodes, sensing electrodes, or pacing / sensing electrodes. Figures 1A to 1C In the illustrated example, the distal portion 16 includes two pacing / sensing electrodes 32a and 32b (collectively referred to as “pacing / sensing electrodes 32 ”).
[0054] In the illustrated example, the pace / sense electrode 32b is positioned between the defibrillation electrodes 28, e.g., within a gap between the defibrillation electrodes, and the pace / sense electrode 32a is positioned closer along the distal portion 16 than the proximal defibrillation electrode 28a. In some examples, there may be more than one electrode 32 within a gap between the defibrillation electrodes 28. In some examples, the electrode 32 is additionally or alternatively located distally of the most distal defibrillation electrode 28b.
[0055] In one example, the distance between the nearest defibrillation electrode 28 and the electrode 32 is greater than or equal to about 2 mm and less than or equal to about 1.5 cm. In another example, the electrode 32 can be spaced greater than or equal to 5 mm and less than or equal to 1 cm from the nearest one of the defibrillation electrodes 28. In an additional example, the electrode 32 can be spaced greater than or equal to 6 mm and less than or equal to 8 mm from the nearest one of the defibrillation electrodes 28.
[0056] The electrodes 32 may be configured to deliver low voltage electrical pulses to the heart or may sense cardiac electrical activity, such as depolarization and repolarization of the heart. Therefore, the electrodes 32 may be referred to herein as pacing / sensing electrodes 32. In one configuration, the electrodes 32 are ring electrodes. However, in other configurations, the electrodes 32 may be any of a variety of different types of electrodes, including ring electrodes, short coil electrodes, paddle electrodes, hemispherical electrodes, or directional electrodes. Each of the electrodes 32 may be an electrode of the same or different type as another electrode 32. The electrodes 32 may be electrically isolated from the adjacent defibrillation electrodes 28 by including an electrically insulating layer of material between the electrode 32 and the adjacent defibrillation electrode 28. Each electrode 32 may have its own separate conductor so that a voltage may be applied to each electrode or sensed via each electrode independently of the other electrode 32.
[0057] Electrode 28 is referred to as a defibrillation electrode, and electrode 32 is referred to as a pacing / sensing electrode, because they may have different physical structures, thereby achieving different functions. Defibrillation electrode 28 may be larger than pacing / sensing electrode 32, for example, having a larger surface area, and thus may be configured to deliver an anti-tachyarrhythmia shock having a relatively higher voltage than a pacing pulse. The relatively smaller size of pacing / sensing electrode 32 may provide advantages over defibrillation electrode for delivering pacing pulses and sensing intrinsic cardiac activity, for example, a lower pacing capture threshold and / or better sensing signal quality. However, defibrillation electrode 28 may be used to deliver pacing pulses and / or sense electrical activity of the heart, such as in combination with pacing / sensing electrode 32.
[0058] exist Figures 1A to 1C In the illustrated configuration, each electrode 32 is substantially aligned along the main longitudinal axis 11. In one example, the main longitudinal axis 11 is defined by a portion of the distal portion 16 (e.g., the substantially linear portion 20). In another example, the main longitudinal axis 11 is defined relative to the body of the patient 12, for example, along the anterior midline (or midsternal line), one of the sternal lines (or lateral sternal line), the left parasternal line, or other lines.
[0059] In one configuration, the midpoint of each electrode 32a and 32b is along the main longitudinal axis 11, so that when the distal portion is implanted in the patient, each electrode 32a and 32b is disposed at least at substantially the same horizontal location. In some examples, the longitudinal axis 11 may correspond to the caudocranial axis of the patient, and the horizontal axis orthogonal to the longitudinal axis 11 may correspond to the mediolateral axis of the patient. In other configurations, the electrodes 32 may be disposed at any longitudinal or horizontal location along the distal portion 16 disposed between, proximal to, or distal to the defibrillation electrodes 28. Figure 1AIn the example illustrated in , the electrode 32 is disposed along the wavy configuration of the distal portion 16 at a location closer to the heart 26 of the patient 12 than the defibrillation electrode 28 (e.g., at the peak of the wavy configuration toward the left side of the sternum). Figure 1A As illustrated in , for example, the electrodes 32 are substantially aligned with each other along the left sternal line. Figure 1A In the example illustrated in , the defibrillation electrode 28 is arranged along the peak of a wave-like configuration extending away from the heart toward the right side of the sternum. This configuration places the pacing / sensing electrode 32 closer to the heart than the electrode 28 to facilitate cardiac pacing and sensing at relatively low amplitudes.
[0060] In some examples, when the distal portion 16 is implanted outside a cardiovascular device, the pacing / sensing electrodes 32 and the defibrillation electrodes 28 may be disposed in a common plane. In other configurations, the wavy configuration may not be substantially disposed in a common plane. For example, the distal portion 16 may define a concavity or curvature.
[0061] The proximal end 14 of the lead body 13 may include one or more connectors 34 to electrically couple the lead 10 to the ICD 9. The ICD 9 may also include a connector assembly including an electrical feedthrough through which an electrical connection is made between the one or more connectors 34 of the lead 10 and the electronic components included in the housing. The housing of the ICD 9 may house one or more processors, memories, transmitters, receivers, sensors, sensing circuits, treatment circuits, power sources (capacitors and batteries), and / or other components. The components of the ICD 9 may generate and deliver electrical therapy, such as anti-tachycardia pacing, cardioversion or defibrillation shocks, post-shock pacing, and / or bradycardia pacing.
[0062] The wavy configuration of distal portion 16 and the inclusion of electrodes 32 between defibrillation electrodes 28 provide multiple therapy vectors for delivering electrical therapy to the heart. For example, at least a portion of defibrillation electrodes 28 and one of electrodes 32 may be disposed over the right ventricle or any chamber of the heart so that pacing pulses and anti-tachyarrhythmia shocks may be delivered to the heart. The housing of ICD 9 may be charged or used as a polarity different from the polarity of one or more defibrillation electrodes 28 and / or electrodes 32 so that electrical energy may be delivered to the heart between the housing and defibrillation electrodes 28 and / or electrodes 32.
[0063] When voltage is applied to each defibrillation electrode 28, each defibrillation electrode may have the same polarity as each other defibrillation electrode 28 so that a defibrillation shock may be delivered together from all defibrillation shocks. In examples where the defibrillation electrodes 28 are electrically connected to a common conductor within the lead body 13, this is the only configuration for defibrillation electrodes 28. However, in other examples, the defibrillation electrodes 28 may be coupled to separate conductors within the lead body 13, and therefore may each have a different polarity, so that electrical energy may flow between the defibrillation electrodes 28, or between one of the defibrillation electrodes 28 and one of the pacing / sensing electrodes 32 or housing electrodes, to provide an anti-tachyarrhythmia shock, pacing therapy, and / or sense cardiac depolarization. In this case, the defibrillation electrodes 28 may still be electrically coupled together, for example, via one or more switches within the ICD 9, to have the same polarity.
[0064] In some examples, the ICD system 8 may include one or more shields 30. The shield 30 or multiple shields may be configured to be implanted in the patient 12 with the implantable lead 10 and / or the distal portion 16 of the lead 10. The shield 30 may be configured to block the electric field from delivering electrical therapy via the electrode, for example, from a pacing pulse and / or an anti-tachyarrhythmia shock, in a direction away from the electrode from the heart (e.g., in a forward direction). In this way, the shield 30 may reduce the likelihood that the electric field will stimulate extracardiac tissues (such as sensory nerves or motor nerves). In addition, the shield 30 may direct the electric field toward the heart, thereby allowing a pacing pulse of the heart to be captured at a lower energy level and / or an anti-tachyarrhythmia shock at a lower energy level than the energy level that may be required without the shield 30. The lower energy pacing pulse may also reduce the likelihood that a pacing pulse delivered via a pacing electrode or a defibrillation pulse delivered via a defibrillation electrode 28 stimulates extracardiac tissues, and may result in less power consumption by the ICD 9, and thus extend the life of the ICD.
[0065] The shield 30 can be further configured to expand and / or inflate in the deployed configuration and to compress and / or shrink in the undeployed configuration. In some examples, the shield 30 is configured to be accommodated by an introducer configured to deliver the lead 10 and, for example, the shield 30 in the undeployed configuration, while still providing a relatively large shielding area in the deployed configuration. In some examples, the shield 30 may have an asymmetric shape that is configured to improve the insertion and removal of the lead 10 including the shield 30, for example, via the insertion and removal of the introducer. It should be understood that various aspects of the technology disclosed herein may be applied to implantable systems other than the ICD 9, including but not limited to bradycardia pacemaker systems. For example, a lead that does not include a defibrillation electrode 28 may include one or more shields 30 and may be used with a pacemaker system that does not have defibrillation capabilities.
[0066] FIG. 2A to FIG. 2B and FIG. 3A to FIG. 3B is a conceptual diagram illustrating a view of an example shield 30 and distal portion 16 of an implantable medical lead 10. In particular, Figure 2A is a conceptual diagram illustrating a front or "top view" of the distal portion 16 of an example implantable medical lead 10 and an example shield 30 in a deployed configuration, and Figure 3A is an example in an unexpanded configuration Figure 2A 1 and 10. Conceptual illustration of a front view of distal portion 16 of an example implantable medical lead 10 and an example shield 30. Figure 2B is an example of Figure 2A A conceptual illustration of a lateral or "side" view of the distal portion 16 of an example implantable medical lead 10 and an example shield 30 in a deployed configuration, and Figure 3B is an example of Figure 3A 2A to 2B are conceptual diagrams of a side view of the distal portion 16 of an example implantable medical lead 10 and an example shield 30 in an undeployed configuration. Figure 2B and FIG. 3A to FIG. 3B .
[0067] like Figure 2A As illustrated, the wavy configuration of the distal portion 16 in the expanded configuration may include multiple peaks along the length of the distal portion. Figure 2A In the illustrated example, the distal portion includes three peaks 24a, 24b, and 24c (collectively referred to as "peaks 24"). However, other configurations may include any number of peaks 24. In the illustrated example, a portion of the distal portion 16 is illustrated as being overlapped by the shield 30. In some examples, the entirety of the distal portion 16 is illustrated as being overlapped by the shield 30 (not shown), for example, extending along the longitudinal axis 11 at least as long as the length 60. FIG. 2A to FIG. 3B In the example shown, the shield 30 is positioned in front of the distal portion 16 relative to the patient 12 .
[0068] Figure 2A The exemplary wavy configuration of the distal portion 16 shown in FIG. 1 may define a peak-to-peak distance 35 that may be variable or constant along the length of the distal portion 16 . Figure 2A In the illustrated configuration, the wavy configuration defines a substantially sinusoidal configuration with a constant peak-to-peak distance 35 of approximately 2.0 cm-5.0 cm. The wavy configuration may also define a peak-to-peak width 37, which may also be variable or constant along the length of the wavy configuration. Figure 2A In the illustrated configuration, the wavy configuration defines a substantially sinusoidal shape, with a constant peak-to-peak width 37 of approximately 0.5 cm-2.0 cm. However, in other cases, the wavy configuration may define other shapes and / or patterns, such as an S-shape, a wave shape, etc.
[0069] The defibrillation electrode 28 may extend along, for example, a majority of the wavy configuration of the distal portion 16, for example, along at least 80% of the wavy portion. The defibrillation electrode 28 may extend along more or less than 80% of the wavy configuration. As another example, the defibrillation electrode 28 may extend along at least 90% of the wavy configuration.
[0070] The defibrillation electrode 28a extends along a substantial portion of the wavy configuration of the distal portion 16 from the proximal end to the peak 24b, e.g., along a substantial portion of a first "wave" associated with the peak 24a, and the defibrillation electrode segment 28b extends along a substantial portion of the wavy configuration from the peak 24b to the distal end of the wavy configuration, e.g., along a substantial portion of a second "wave" associated with the peak 24c). Figure 2A In the illustrated example, the portion of the wavy configuration on which the defibrillation electrode 28 is not disposed is the gap between the defibrillation electrodes 28a and 28b on the peak 24b where the electrode 32b is disposed.
[0071] like Figure 2A and Figure 2B As illustrated, distal portion 16 of lead 10 may include lead body portion 40a and lead body portion 40b (collectively referred to as "lead body portion 40"). Lead body portion 40 extends between a respective one of pacing / sensing electrode 32b and defibrillation electrode 28. Lead body portion 40 may provide a relatively flat or smooth surface transition between the outer contour of pacing / sensing electrode 32b and the outer contour of defibrillation electrode 28. Conductors coupled to electrodes 32b and 28b may extend through lead body portion 40a, and conductors coupled to electrode 28b may extend through lead body portion 40b. Lead body portions 40a and 40b may be formed of one or more polymers, which may be the same or different than shields 30 and 31 and / or other portions of lead body 13.
[0072] like FIG. 2A to FIG. 3B As shown, the distal portion 16 of the lead 10 can include a shield 30. In the illustrated example, the shield 30 is positioned on the peaks 24b of the wavy configuration of the distal portion 16. In some examples, the shield 30 can be positioned anywhere along the distal portion 16, for example, so as to "cover" or be located in front of at least a portion of one or more of the pacing / sensing electrodes 32 or defibrillation electrodes 28. In the example shown, the shield 30 covers or is otherwise disposed on a portion of the outer surface of the pacing / sensing electrode 32b. The shield 30 does not cover the entire outer surface of the pacing / sensing electrode 32b, for example, circumferentially surrounds the pacing / sensing electrode 32b.
[0073] In the example shown, the shield 30 has a substantially oval shape. Figure 2AIn the example shown, the shield 30 has an elliptical shape with two axes of symmetry, namely a major axis along the direction of the longitudinal axis 11 (e.g., the y-direction) and a minor axis along the width direction (e.g., the x-direction). For example, the longitudinal axis of the shield 30 is along the length 60 of the distal portion 16 of the implantable medical lead 10. In the example shown, the shield 30 extends along at least a portion of the defibrillation electrode 28. In other examples, in the deployed configuration, the shield 30 extends at least along the entire length 60 and width 37 of the distal portion 16, for example, covering the defibrillation electrode 28 and the pacing / sensing electrode 32. In some examples, the major axis of the shield 30 can be substantially aligned with the longitudinal axis of the distal portion 16.
[0074] In the example shown, the shield 30 is asymmetric along any other axis. In some examples, the shield 30 can be asymmetric about the longitudinal axis and / or the width axis relative to the distal portion 16 and the longitudinal axis 11, for example, the shield 30 can be "rotated" about the z-axis relative to the distal portion 16, and its major axis and minor axis are along directions other than the longitudinal axis 11. For example, when the distal portion 16 is in the deployed configuration, the shield 30 can be rotated to provide better shielding relative to the patient's anatomy. In some examples, the shield 30 can be rotated to provide better mechanical compatibility with the wavy shape of the distal portion 16, for example, to relieve tension via the attachment point of the shield to the distal portion 16, thereby compressing, expanding or twisting the distal portion 16 due to the elastic or shape memory properties of the shield 30, thereby allowing the shield 30 to expand when deployed. In some examples, the shield 30 can be rotated to provide a larger attachment area to the distal portion 16. In some examples, the shield 30 may be rotated or unrotated and / or offset (e.g., in the x-direction and / or y-direction) or unoffset for the same reasons as described above, for example, to provide improved shielding relative to the patient's anatomy, improved mechanical compatibility with the distal portion 16, and / or an improved attachment area with the distal portion 16. In some examples, the shield 30 may have any other suitable shape. In some examples, the shield 30 has a generally asymmetrical shape with its longitudinal axis corresponding to the direction of greatest extent and / or length of the shield 30.
[0075] Shield 30 can be electrically insulating and biocompatible. In some examples, shield 30 includes a polymer, such as polyurethane. In some examples, shield 30 is configured to be folded or wrapped around pacing / sensing electrode 32b for delivery via a cavity of an implantation tool, and is configured to elastically expand or open to a relaxed state when released from the cavity, such as Figure 2A2 . The shield 30 is shown in the expanded configuration. In some examples, the shield 30 includes an elastic or superelastic polymer or metal structure, such as a nitinol structure, to facilitate expansion of the shield 30, support articulation of the shield 30, and / or support the shield 30 in an expanded, relaxed configuration. The expanded and / or articulated configuration may be substantially planar, as illustrated in FIG. 2 , or may be non-planar. For example, a portion of the shield 30 that is laterally spaced farther away from the pacing / sensing electrode 32b may be positioned more posteriorly, e.g., in a cup or bowl shape, compared to a portion closer to the electrode. In some examples, the shield 30 may be a substantially solid material, and in other examples, the shield 30 may have a structure in at least a portion of its area and / or volume, e.g., at least a portion of the shield 30 may be a membrane mesh.
[0076] Such support structures may be partially or completely embedded within the main material of the shield 30, or attached to one or more outer surfaces of the shield 30. In some examples, the support structures are positioned circumferentially around the periphery of the shield 30, e.g., laterally spaced a maximum distance from the shield. However, other support structure locations are possible. For example, one or more support structures may extend from the electrode in a radial or lateral direction, e.g., from near the electrode to near the periphery of the shield.
[0077] In some examples, shield 30 may be a single layer of material and may be substantially flat or planar as described above. Figure 2B As illustrated, the shield 30 extends substantially in the xy plane, has a thickness in the z direction, and has no bends and / or kinks in the positive or negative z direction, and the thickness of the shield 30 is substantially constant across its entire area. In other examples, the shield 30 may have bends and / or kinks, or may be concave and / or convex with respect to the z direction, or may have a thickness variation across its entire area.
[0078] In some examples, shield 30 can be inflatable, such as a balloon. Inflatable shield 30 can be configured to be inflated with at least one of a gas or a liquid. For example, inflatable shield 30 can be configured to be inflated with sterile water, sterile saline, saline contrast agent mixture, etc. In some examples, at least one of lead 10 and distal portion 16 includes a cavity configured to couple with inflatable shield 30, and the cavity can be configured to provide gas or liquid to and from inflatable shield 30.
[0079] In some examples, the inflatable shield 30 can be a single layer of material, or a multilayer material, such as two or more layers of polyurethane. For example, the shield 30 can include a first layer of polyurethane cast along at least a portion of the length 60 and in some examples along the entire length 60. The casting can bond the first layer to at least a portion of the defibrillation electrode 28, and can bond the defibrillation electrode 28 to the appropriate position. The inflatable shield 30 can include holes or openings proximate to the pacing / sensing electrode 32b, for example, to vent the inflatable shield 30 at the front side of the inflatable shield 30. The shield 30 can include a second preformed layer of polyurethane to cover the desired area, and the edges of the second layer can be bonded to the first layer and / or the distal portion 16, for example, via an adhesive, thermal bonding, or any suitable bonding material or technique.
[0080] In some examples, the inflatable shield 30 can be configured to receive an inflation medium, for example, via a hole / aperture from an inflation needle that is inserted into the lumen of the lead 10, for example, near the distal end of the connector gripping sleeve. In some examples, the inflatable shield 30 can be configured to be inflated via a small inflation tube. In other examples, the inflatable shield 30 can be inflated via an inflation needle that is directly inserted into a connector (such as a DF4 connector) at the proximal end 14 of the lead body 13. In some examples, the proximal end 14 of the lead body 13 can include a terminal and / or connector that is fluidly coupled to a lumen (e.g., an inflation lumen) through the lead body 13, which is also fluidly coupled to the inflatable shield 30.
[0081] In some examples, an inflation needle may not be required. For example, the proximal end of the inflation cavity of the lead body 13 can be configured to receive the tube via a friction fit or be received within the tube. In some examples, a cap can be used to fluid-tighten, or improve or ensure the fluid-tightness between the tube and the cavity at the proximal end of the lead body 13, and the tube can be connected to a fluid source that is configured to provide fluid to inflate the inflatable shield 30.
[0082] In some examples, the inflatable shield 30 can be configured to be implanted and / or delivered via a relatively small introducer (e.g., 36 Fr or less, or 20 Fr or less, or 18 Fr or less, or 14 Fr or less, or 12 Fr or less, or any suitable size introducer). For example, the inflatable shield 30 can include a balloon wall thickness such that the inflatable shield 30 can be implanted and / or delivered via a 14 Fr introducer.
[0083] exist Figure 2A and Figure 2B In the example shown, the shield 30 (non-inflatable shield 30 or inflatable shield 30) and the distal portion 16 are in an expanded configuration. Figure 2A and Figure 2B The illustrated shield 30 and distal portion 16 have been introduced via the introducer 62. For example, the distal portion 16 including the shield 30 can be positioned at a delivery site of a cavity having the introducer 62, and the introducer 62 can be pulled back from the distal portion 16 so that the distal portion 16 exits the cavity, or the distal portion 16 can be pushed out of the cavity. Upon exiting the cavity, the distal portion 16 and the shield 30 can be configured to self-expand into an expanded configuration, such as described above. Figure 2A and Figure 2B For example, the distal portion 16 and shield 30 can be elastic and compressed in the lumen of the introducer 62 and can self-expand to their relaxed state shape when released from the lumen. In some examples, the distal portion 16 and / or shield 30 can have shape memory and can self-expand to their designed shape when released from the introducer 62.
[0084] Figure 3A and Figure 3B The distal portion 16 in the undeployed configuration and the shield 30 compressed to a first shape for implanting the lead 10 are illustrated, for example. For example, the undulating shape of the distal portion 16 can be substantially straight, and in the first shape, for example, when the shield 30 is compressed, unexpanded, deflated or uninflated and / or undeployed, the electrodes 28 and 32 are configured to be substantially aligned along a common axis. In the example shown, the distal portion 16 and the shield 30 in the undeployed configuration are located within the lumen of the introducer 62, and the shield 30 can be compressed and / or wrapped around the distal portion 16 in the first shape of the undeployed configuration within the introducer 62. When deployed, the distal portion 16 can be configured to elastically expand to its undulated shape, and the shield 30 can be configured to elastically expand to its second shape, which can be asymmetric, kidney bean-shaped, elliptical, or any other suitable shape. When removed, the distal portion 16 and the shield 30 can be configured to be compressed, deflated, etc. to the first shape.
[0085] In the deployed configuration, the shield 30 expanded to an asymmetric shape is greater than the length of the pacing electrode 32b, and the width of the shield 30 expanded to an asymmetric shape is greater than the width of the pacing electrode 32b. In some examples, the shield 30 in the expanded, deployed configuration is configured to extend at least 10 millimeters from the pacing electrode 32b in any lateral direction. In some examples, the length of the shield 30 expanded to an asymmetric shape in the deployed configuration is greater than the length 60 of the distal portion 16, and the width of the shield 30 expanded to an asymmetric shape is greater than the width 37 of the distal portion 16. In some examples, the shield 30 is configured to retract into the introducer 62, such as during removal of the distal portion 16 and the lead 10. For example, the distal portion 16 can be configured to retract and / or compress into the introducer 62, and the introducer 62 is advanced along the distal portion 16, or the distal portion 16 is retracted into the lumen of the introducer 62. The shield 30 can be configured to collapse and / or compress with the distal portion 16 , for example, from its second shape in the deployed configuration to its first shape in the undeployed configuration.
[0086] Figure 4 is a conceptual cross-sectional view illustrating an implantable medical lead 10 and an electrode 32 b of a shield 30 . Figure 4 is Figure 2B A cross-sectional view taken along the line A-A' in FIG. Figure 4 As illustrated in FIG. 1 , the pacing / sensing electrode 32 b may define a cavity 53, which may be annular, for example, and a conductor coupled to the electrode 28 b may extend through the cavity 53. Figure 4 , the pacing / sensing electrode 32 may have other shapes, including partial or segmented rings or arcs, in which one or more electrodes or electrode segments extend less than 360 degrees around the circumference of the lead.
[0087] Because shield 30 covers only a forward portion of the outer surface of one or more of electrodes 28 and / or 32 (e.g., surface 43 of pacing / sensing electrode 32b in the illustrated example), depth 49 of shield 30 may be less than the depth of electrodes 28 and / or 32 (e.g., depth 51 of pacing / sensing electrode 32b in the illustrated example), such as less than half the depth of either electrode 28 and / or 32. Although illustrated as being substantially constant, depth 49 of shield 30 may vary. For example, depth 49 may increase toward electrodes 28 and / or 32 and / or decrease toward an edge of shield 30, e.g., to provide a smooth or other desired transition between shield 30 and electrodes 28 and / or 32 and / or between shield 30 and tissue of the patient. Furthermore, although defibrillation electrodes 28, pacing / sensing electrodes 32, and lead body portions 40a and 40b are disposed at the same depth, the depth 49 of shield 30 may be less than the depth of electrodes 28 and / or 32 (e.g., depth 51 of pacing / sensing electrode 32b in the illustrated example), such as less than half the depth of either electrode 28 and / or 32. Figure 2BShield 30 is shown as having a substantially equal depth (e.g., circumference) greater than the depth 49 of shield 30, but in other examples, the depth 49 of shield 30 can be similar to the depth of lead body portions 40a and 40b, and pacing / sensing electrode 32b can extend outward from lead body portions 40a and 40b and shield 30, for example, due to having a greater depth or being offset from the longitudinal axis defined by lead body portions 40a and 40b. In some examples, for example, for an inflatable shield 30, the depth 49 of shield 30 can be greater than the depth of electrodes 28 and / or 32.
[0088] like Figure 4 , pacing pulses delivered by the ICD 9 via the pacing / sensing electrode 32 b produce an electric field 55 near the electrode that “spreads” from the electrode outer surface 43. Similarly, although not shown, anti-tachyarrhythmia shocks delivered by the ICD 9 via the defibrillation electrode 28 produce an electric field near the electrode that spreads from the electrode outer surface, similar to the electric field shown for the pacing / sensing electrode 32 b. The shield 30 reduces and / or blocks the electric field in a direction from the electrode toward the shield, and allows diffusion in a direction from the electrode away from the shield 30. In this manner, the shield 30 can be configured to make either or all of the pacing / sensing electrodes 32 and the defibrillation electrodes 28 directional.
[0089] like Figure 2A , in the deployed configuration, the shield 30 can extend laterally away from the pacing / sensing electrode 32b, for example in a substantially planar manner, such that the dimension of the shield 30 in the plane is greater than the dimension of the pacing / sensing electrode 32b in the plane. In this manner, the shield 30 can additionally (or more effectively) limit the direction of spread, for example, radial angle, of the electric field generated by the pacing pulse from the pacing / sensing electrode 32b. The plane in which the shield 30 extends laterally from the pacing / sensing electrode 32b can be the same plane in which the peaks 24 of the wavy configuration extend, or a substantially parallel plane.
[0090] The portion of the outer surface of the pacing / sensing electrode 32b on which the shield 30 is located can be referred to as the "forward portion" of the outer surface of the pacing / sensing electrode 32b because the portion of the pacing / sensing electrode 32b can be positioned more forwardly in the patient's body when the distal portion 16 of the lead 10 is implanted in the patient's body. When the shield 30 is positioned over the forward portion of the outer surface of the pacing / sensing electrode 32b, the shield 30 can be positioned forwardly relative to the central longitudinal axis 11 of the pacing / sensing electrode 32b. Figures 1A to 1C As described in , when the shield 30 is positioned over the forward portion of the outer surface of the pacing / sensing electrode 32b and the distal portion 16 is implanted in the patient, the shield 30 can block the electric field in a direction away from the heart 26, referred to as the forward direction.
[0091] In some examples, the shield 30 includes a plurality of radiopaque markers, including a radiopaque marker 42a and a radiopaque marker 42b (collectively referred to as "radiopaque markers 42"). The shield 30 may include any number of radiopaque markers or no radiopaque markers. The radiopaque markers 42 may be distributed on the shield 30 symmetrically or asymmetrically, for example, relative to the pacing / sensing electrode 32b. The radiopaque markers 42 may be positioned on the shield 30 to allow a user to visualize at least one of the position or orientation of the shield in the patient's body by identifying the radiopaque markers in a fluoroscopic or other image. The radiopaque markers 42 may differ from one another in one or more ways, such as size, shape, or orientation, to allow, for example, a physician to distinguish the radiopaque markers 42, in such a way as to facilitate visualization of the orientation of the shield 30. For example, one of the radiopaque markers 42 positioned on the shield 30 may be larger than the remaining markers, so that the physician may determine the orientation of the shield 30 based on the position of the larger radiopaque marker (e.g., relative to the remaining markers of the radiopaque marker 42).
[0092] Figure 5A 2 to 3 are conceptual diagrams illustrating a front view of another example implantable medical lead 10 distal portion 16 and another example shield 530 in an expanded configuration. The lead 10 and distal portion 16 may be as described above in FIG. Figure 4 Shield 530 may be substantially similar to shield 30 described above, but have a different shape.
[0093] In the example shown, shield 30 has a "kidney bean" shape, which may be generally asymmetrical. In some examples, shield 530 may have one axis of symmetry, such as along the x-direction shown, or no axis of symmetry. In some examples, shield 530 may have a shape substantially similar to the oval shape of shield 30, but with a notch on one side of the oval shape.
[0094] In some examples, the shield 530 can be configured to improve deployment and removal of the lead 10, for example by improving deployment and removal of the distal portion 16 and the shield 530. For example, the notch shape of the shield 530 can generally follow the shape of the distal portion 16 between the peaks 24a and 24c. The shape of the shield 530 and optionally the atraumatic edge can improve the retraction of the distal portion 16 and the shield 530 into the introducer 62 by reducing excess shield material and rough edges that may, for example, get caught and / or "hang" on the introducer 62 at the edge of the distal end cavity opening of the introducer 62. In some examples, the kidney bean shape of the shield 530 can relieve stress between the distal portion 16 and the shield 530 bonded and / or attached along at least a portion of the length of the distal portion 16. In some examples, the kidney bean shape of the shield 530 can be configured to improve blocking of electrical signals in the forward direction to portions of the anatomy of the patient 12.
[0095] Figure 5B 2 to 3 are conceptual diagrams illustrating a front view of another example implantable medical lead 10 distal portion 516 and another example shield 550 in an expanded configuration. The lead 10 and distal portion 16 may be as described above in FIG. Figure 4 Shield 530 may be substantially similar to shield 30 described above, but have a different shape.
[0096] In the example shown, the shield 550 has a reduced width and length relative to the shield 30. For example, in the deployed configuration, the shield 550 can be configured to extend to shield the pace / sense electrode 32b and a portion of the defibrillation electrodes 28a and 28b adjacent to the lead body portions 40a and 40b. For example, the shield 550 can extend to shield 90% or less of the defibrillation electrodes 28a and 28b, or 50% or less of the defibrillation electrodes 28a and 28b, or 10% or less of the defibrillation electrodes 28a and 28b.
[0097] In some examples, shield 550 can be configured to improve deployment and removal of lead 10, for example, by reducing the size relative to shield 30 to improve deployment and removal of distal portion 16 and shield 550, while still shielding pace / sense electrode 32b and edge effects created by defibrillation electrodes 28a and 28b (e.g., at the edges of defibrillation electrodes 28a and 28b adjacent lead body portions 40a and 40b). The shape and optionally atraumatic edges of shield 550 can improve retraction of distal portion 16 and shield 550 into introducer 62 by reducing excess shield material and rough edges that may catch and / or "hang" on introducer 62, for example, at the edges of the distal end cavity opening of introducer 62. In some examples, shield 550 can be configured to improve blocking of electrical signals in a forward direction of the anatomical structure portion of patient 12.
[0098] Figure 6 2 to 3 are conceptual diagrams illustrating a front view of another example distal portion 616 and another example shield 630 of an example implantable medical lead 10 in an expanded configuration. The lead 10 and the distal portion 616 may be substantially similar to those described above in FIGS. Figure 4 , but with a reshaped distal portion 616. Shield 630 may be substantially similar to any of shields 30 and / or 530 described above, but with a different shape.
[0099] In the example shown, the distal portion 616 has a different wavy shape relative to the distal portion 16. For example, peak 624b is offset from the longitudinal axis 11 in the x-direction toward peaks 624a and 624c. In some examples, the distal portion 616 can have a length 660 that can be about the same as the distal portion 16. Figure 5A The length 60 of the distal portion 16 is the same as, longer than, or shorter than. The distal portion 616 can have a peak-to-peak length 635 that is equal to, longer than, or shorter than Figure 5A The length 35 of the distal portion 16, and the distal portion 616 can have a width 637 that is equal to, longer than, or shorter than Figure 5A The width 37 of the distal portion 16 .
[0100] In some examples, the shield 630 can be attached and / or bonded to the distal portion 16 along its entire length, for example, following the wavy shape of the distal portion 16. The shape of the distal portion 616 can enable or improve the bonding of the shield 630 to the distal portion 616 along its entire length 660 (e.g., along at least a portion or substantially all of the wavy shape of the electrodes 28 and 32 and the lead body portions 40a and 40b). In some examples, the shield 630 can be a thin, stretchable elastic film that is configured to return to its original shape in the deployed configuration (as shown). In some examples, the shield 630 is configured to improve lead stability and ensure its deployment by bonding to at least two defibrillation electrodes 28a and 28b.
[0101] In some examples, the shield 630 is configured to reduce or prevent tissue ingrowth between the shield 630 and the distal portion 616, such as by being bonded along the entire length of the distal portion 616 and / or the shield 630. The shield 630 can be configured to release from the tissue when removed, such as by a bond that prevents ingrowth between the shield 630 and the distal portion 616, or via any other means of release from the tissue (such as a coating, such as a hydrophobic and / or oleophobic coating), or via a stretch release mechanism (the stretch release mechanism is configured to separate or peel the shield 630 from the surrounding tissue by means of stretching and / or compression of the shield 630). In some examples, the shield 630 is tapered and bonded to one or both of the distal end and the proximal end of the distal portion 616. In some examples, tapering and bonding the shield 630 at one or both of the distal end and the proximal end of the distal portion 616 can improve deployment and / or removal of the distal portion 616 and the shield 630, and can reduce the distal portion 616 and the shield 630 from getting stuck and / or hanging on the introducer 62 and / or the introducer valve during deployment and / or removal.
[0102] Figure 7 2 to 3 are conceptual diagrams illustrating a front view of an example distal portion 16 of an example implantable medical lead 10 and another example shield 730 in an expanded configuration. The lead 10 and distal portion 16 may be as described above with reference to FIGS. Figure 4 Shield 730 can be substantially similar to any of shields 30, 530, and / or 630, and pacing / sensing electrode 732b can be substantially similar to pacing / sensing electrode 32b described above, but pacing / sensing electrode 732b can be configured to extend laterally with shield 730. For example, pacing / sensing electrode 732b can be bonded and / or attached to shield 730.
[0103] The shield 730 may be an inflatable shield configured to move the pacing / sensing electrode 732b laterally when inflated. In some examples, the shield 730 may be configured to move the pacing / sensing electrode 732b to improve the sensing vector, improve the delivery of pacing pulses, reduce the electric field delivery at the location of the patient 12, etc. In some examples, the shield 730 may be configured to allow a cable to be connected to the pacing / sensing electrode 732b once it is laterally offset in the deployed configuration, for example, the shield 730 may include a button hole, an opening, a rivet, or any suitable structure to allow a cable to extend from the distal portion 16 to the pacing / sensing electrode 732b via the shield 730. In some examples, the distal portion 16 may include the pacing / sensing electrode 32b, and the shield 730 may include the pacing / sensing electrode 732b, for example, as an additional pacing / sensing electrode. In some examples, shield 730 can include a plurality of laterally extending pacing / sensing electrodes 732b, e.g., extending in a longitudinal direction, a width direction, and / or any other suitable direction. In some examples, shield 730 can be configured to be attached and / or bonded to distal portion 16 along its entire length (e.g., length 60).
[0104] Figure 8 2 to 3 are conceptual diagrams illustrating a side view of an example distal portion 16 of an example implantable medical lead 10 and another example shield 830 in an expanded configuration. The lead 10 and distal portion 16 may be as described above in FIGS. Figure 4 The pacing / sensing electrode 832b and the shield 830 can be substantially similar to any of the shields 30, 530, 630, and / or 730 and the pacing / sensing electrode 32b described above, but the pacing / sensing electrode 832b can be configured to extend backward toward the patient's heart with the shield 830. For example, the pacing / sensing electrode 832b can be bonded and / or attached to the shield 830.
[0105] The shield 830 can be an inflatable shield that is configured to move the pacing / sensing electrode 832b backward toward the patient's heart when expanded, for example, when inflated. In some examples, the shield 830 can be configured to move the pacing / sensing electrode 832b to improve the sensing vector, improve the delivery of pacing pulses, reduce the electric field delivery at the location of the patient 12, etc. In some examples, the shield 830 can be configured to allow a cable to be connected to the pacing / sensing electrode 832b once it is laterally offset in the deployed configuration, for example, the shield 830 can include a button hole, an opening, a rivet, or any suitable structure to allow a cable to extend from the distal portion 16 to the pacing / sensing electrode 832b via the shield 830. In some examples, the distal portion 16 can include the pacing / sensing electrode 32b, and the shield 830 can include the pacing / sensing electrode 832b, for example, as an additional pacing / sensing electrode. In some examples, shield 830 can include a plurality of laterally extending pacing / sensing electrodes 832b, e.g., in a longitudinal direction, a width direction, and / or any other suitable direction. In some examples, shield 830 can additionally or alternatively be configured to move distal portion 16 toward the heart of patient 12 when expanded, deployed, and / or inflated. In some examples, shield 830 can be configured to be attached and / or bonded to distal portion 16 along its entire length (e.g., length 60).
[0106] Fig. 9 is a conceptual diagram illustrating a front view of an example distal portion 916 and another example shield 930 of an example implantable medical lead 10 in an expanded configuration. The distal portion 916 and shield 930 may be substantially similar to those described above. Figures 7 and 8 830, but with a substantially straight distal portion 916, for example, the electrodes 28 and 32a are configured to be substantially aligned along a common axis. For example, the defibrillation electrode 28 can be configured to be substantially along a common axis in the deployed configuration, for example, when the shield 830 is expanded and / or inflated.
[0107] In the example shown, the pacing / sensing electrodes 932b can be substantially similar to the pacing / sensing electrodes 732b and / or 832b described above, e.g., the pacing / sensing electrodes can be configured to extend laterally and / or posteriorly toward the heart of the patient 12 with the shield 930. For example, the pacing / sensing electrodes 932b can be bonded and / or attached to the shield 930.
[0108] In some examples, the shield 930 may include a plurality of pacing / sensing electrodes 932b (which may otherwise be substantially similar to the pacing / sensing electrodes 32a) and one or more defibrillation electrodes. The shield 930 may be configured to move either of the pacing / sensing electrodes 932b and / or the defibrillation electrodes (not shown) away from a common axis. For example, the shield 930 may allow the pacing / sensing electrodes or the defibrillation electrodes to deviate from a common axis of the lead body, such as the distal portion 916 and / or the longitudinal axis 11, while making the distal portion 916 substantially straight, such as without a wavy shape. In some examples, the shield 930 may be configured to be attached and / or bonded to the distal portion 916 along its entire length (e.g., length 60), and may be configured to taper at one or both of the distal end and the proximal end of the distal portion 916, for example, to enable a smooth transition through the introducer 62 and improve removability.
[0109] Fig.10 is a flow chart illustrating an example technique for implanting an implantable medical lead that includes a shield. Fig.10 An implantable medical lead 10, a distal portion 16, and a shield 30 are described. However, Fig.10 The example techniques may be used to implant other leads and / or shields, such as any lead, distal portion of the shields described herein.
[0110] A medical practitioner can use an implantation tool to position and / or implant the distal portion 16 of an implantable medical lead 10 under the sternum or in other extravascular locations (1002). In some examples, the distal portion 16 can be loaded into a cavity and packaged in a sterile package, for example, by a manufacturer of the lead 10 and / or implantation tool before the implantation procedure. The cavity of the implantation tool can be cylindrical, or can otherwise have a profile that matches the outer contour of the distal portion 16, for example, in an undeployed configuration. The wavy configuration of the distal portion 16 can be straightened in the cavity. In one example, the cavity can include a sheath. The present disclosure contemplates configurations other than those configurations of the cavity of the implantation tool including a shield 30 for release.
[0111] In some examples, a medical practitioner can introduce an implantation tool into the patient via a subxiphoid incision, and advance the implantation tool to an extravascular position. Advancing the tool to an extravascular position can occur before or after the implantable medical lead 10 is loaded into the tool. In either case, the implantation tool is used, for example, to advance through the cavity or to advance the tool when in the cavity, and the distal portion 16 of the lead 10 is positioned at an extravascular position. In one embodiment, the implantation tool may include a tunneling tool having a rod or other tunneling member and a sheath configured to be placed on the rod. A medical practitioner can remove the distal portion 16 of the lead 10 from the implantation tool to position the distal portion 16 at the implantation position and / or site.
[0112] The medical practitioner may inflate and / or deploy the shield 30 from a first shape of an undeployed configuration to a second shape of a deployed configuration (1004). In some examples, the deployed shape of the shield 30 may be larger than the undeployed configuration, and the shield 30 may be asymmetric in the deployed configuration.
[0113] In some examples, the medical practitioner can use an implantation tool to remove 1006 the distal portion 16 and shield 30 of the implantable medical lead 10. For example, the shield 30 can be configured to release from the tissue when removed, and the medical practitioner can advance the introducer, or retract the distal portion 16 to compress the distal portion 16 and / or shield 30 into the lumen of the introducer.
[0114] Fig.11 is a flow chart illustrating another example technique for implanting an implantable medical lead that includes a shield. Fig.11 An implantable medical lead 10, distal portion 16, and shield 730 are described. However, Fig.11 The example techniques may be used to implant other leads and / or shields, such as any lead, distal portion of the shields described herein.
[0115] The medical practitioner may use an implantation tool to position and / or implant the distal portion 16 of the implantable medical lead 10 in a substernal or other extravascular location (1102), for example, similar to that described above at (1002). The medical practitioner may inflate the shield 730 from a first shape of an undeployed configuration to a second shape of an deployed configuration (1104). In some examples, the deployed shape of the shield 730 may be larger than the undeployed configuration.
[0116] The shield 730 can move the distal portion 16 toward the heart of the patient 12 when inflated (1106). For example, the shield 730 can be a balloon located in front of the distal portion 16 and can push against the anatomical structure of the patient 12 to push the distal portion 16 toward the heart. The shield 730 can move the pacing / sensing electrode 732b laterally when inflated (1108). For example, the pacing / sensing electrode 732b can be attached and / or bonded to the shield 730 and can move laterally away from the longitudinal axis 11 when the shield 730 is inflated. The shield 730 can move the pacing / sensing electrode 732b backward toward the heart of the patient 12 when the shield 730 is inflated (1110). Although 1108 and 1110 are depicted as separate steps, 1108 and 1110 can occur together, for example, close to or simultaneously when the shield 730 is inflated.
[0117] In some examples, the medical practitioner can use an implantation tool to remove 1112 the distal portion 16 and shield 730 of the implantable medical lead 10. For example, shield 730 can be configured to compress and / or shrink and release from tissue when removed, and the medical practitioner can advance the introducer, or retract the distal portion 16, to compress the distal portion 16 and / or shield 730 into the lumen of the introducer.
[0118] Fig.12 4 is a functional block diagram of an example configuration of electronic components and other components of ICD 9. ICD 9 includes processing circuitry 402, sensing circuitry 404, therapy delivery circuitry 406, sensor 408, communication circuitry 410, and memory 412. In other examples, ICD 9 may include more or fewer components. The described circuits and other components may be implemented together on shared hardware components, or separately as discrete but interoperable hardware or software components. The depiction of different features is intended to highlight different functional aspects and does not necessarily imply that such circuits and other components must be implemented by separate hardware or software components. Instead, the functions associated with one or more modules or circuits and components may be performed by separate hardware or software components, or integrated within shared or separate hardware or software components.
[0119] The sensing circuit 404 may be electrically coupled to some or all of the electrodes 416, which may correspond to any of the defibrillation electrodes, pacing / sensing electrodes, and housing electrodes described herein. The sensing circuit 404 is configured to obtain signals sensed via one or more combinations of the electrodes 416 and process the obtained signals.
[0120] The components of the sensing circuit 404 may be analog components, digital components, or a combination thereof. The sensing circuit 404 may, for example, include one or more sensing amplifiers, filters, rectifiers, threshold detectors, analog-to-digital converters (ADCs), and the like. The sensing circuit 404 may convert the sensed signal into digital form and provide the digital signal to the processing circuit 402 for processing or analysis. For example, the sensing circuit 404 may amplify the signal from the sensing electrode and convert the amplified signal into a multi-bit digital signal through the ADC. The sensing circuit 404 may also compare the processed signal with a threshold value to detect the presence of atrial depolarization or ventricular depolarization (e.g., a P wave or an R wave) and indicate the presence of atrial depolarization (e.g., a P wave) or ventricular depolarization (e.g., an R wave) to the processing circuit 402. Fig.12 As shown, the ICD 9 may additionally include one or more sensors 408, such as one or more accelerometers, which may be configured to provide signals to the processing circuit 402 indicative of other parameters of the patient, such as activity or posture.
[0121] The processing circuit 402 may process signals from the sensing circuit 404 to monitor the electrical activity of the heart 26 of the patient 12. The processing circuit 402 may store the signals obtained by the sensing circuit 404 and any generated EGM waveforms, marker channel data, or other data derived based on the sensed signals in the memory 412. The processing circuit 402 may analyze the EGM waveforms and / or marker channel data to detect arrhythmias (e.g., bradycardia or tachycardia). In response to detecting a cardiac event, the processing circuit 402 may control the therapy delivery circuit 406 to deliver a desired therapy to treat the cardiac event, such as a defibrillation shock, a cardioversion shock, ATP, post-shock pacing, or bradycardia pacing.
[0122] The therapy delivery circuit 406 is configured to generate electrical therapy and deliver the electrical therapy to the heart 26. The therapy delivery circuit 406 may include one or more pulse generators, capacitors, and / or other components capable of generating and / or storing energy for delivery as pacing therapy, defibrillation therapy, cardioversion therapy, cardiac resynchronization therapy, other therapy, or a combination of therapies. In some cases, the therapy delivery circuit 406 may include a first set of components configured to provide pacing therapy and a second set of components configured to provide defibrillation therapy. In other cases, the therapy delivery circuit 406 may utilize the same set of components to provide both pacing therapy and defibrillation therapy. In still other cases, the therapy delivery circuit 406 may share some of the defibrillation therapy components and the pacing therapy components, while using other components only for defibrillation or pacing. The processing circuit 402 may control the therapy delivery circuit 406 to deliver the generated therapy to the heart 26 via one or more combinations of electrodes 416. Although Fig.10 Not shown, but ICD 9 may include switching circuitry configurable by processing circuitry 402 to control which of electrodes 416 is connected to therapy delivery circuitry 406 and sensing circuitry 404 .
[0123] Communication circuitry 410 includes any suitable hardware, firmware, software, or any combination thereof for communicating with another device, such as a clinician programmer, a patient monitoring device, etc. For example, communication circuitry 410 may include appropriate modulation components, demodulation components, frequency conversion components, filtering components, and amplifier components for transmitting and receiving data via an antenna.
[0124] The various components of ICD 9 may include any one or more processors, controllers, digital signal processors (DSPs), application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), or equivalent discrete or integrated circuits, including analog circuits, digital circuits, or logic circuits. Processing circuitry 402 may include fixed function circuitry and / or programmable processing circuitry. The functions attributed to processing circuitry 402 herein may be embodied in software, firmware, hardware, or any combination thereof.
[0125] Memory 412 may include computer readable instructions that, when executed by processing circuit 402 or other components of ICD 9, cause one or more components of ICD 9 to perform various functions attributed to those components in the present disclosure. Memory 412 may include any volatile, nonvolatile, magnetic, optical, or electronic media, such as random access memory (RAM), read-only memory (ROM), nonvolatile RAM (NVRAM), static nonvolatile RAM (SRAM), electrically erasable programmable ROM (EEPROM), flash memory, or any other nonvolatile computer readable storage medium.
[0126] FIG. 13A to FIG. 13J are conceptual diagrams, each illustrating a front view of a distal portion of various example implantable medical leads having various shapes and various example shields having various shapes and sizes (e.g., having different surface areas), each shield in an expanded configuration covering a different area of the distal portion of the implantable medical lead. Fig.13I In the example shown, shield 1330i is attached to the distal portion of the medical lead via a suture. In some examples, the suture can be configured to dissolve and / or be absorbed by the patient over a period of time, for example. For example, the suture can attach shield 1330i to the distal portion during delivery and deployment, and then dissolve and / or be absorbed by the patient, and the shield can no longer be attached to the distal portion. If the medical lead is removed and / or withdrawn from the patient, shield 1330i can be configured to be removed separately from the medical lead.
[0127] exist FIG. 13A to FIG. 13H and Fig.13J In the example shown, shields 1330a-1330h and 1330j can be bonded to the distal portion along the entire length of the wavy shape of the distal portion within the length / width of the shield and are configured to prevent tissue ingrowth between the shield and the lead. For example, bonding along the entire length of each of the shields can prevent tissue from growing around at least a portion of the circumference of the distal portion bonded to shields 1330a-1330h and 1330j. In some examples, bonding can improve the releasability of the distal portion and / or the medical lead during removal and / or withdrawal of the medical lead, for example by preventing tissue ingrowth between shields 1330a-1330h and 1330j and each corresponding distal portion.
[0128] Fig.141 is a conceptual diagram illustrating a front view of another example implantable medical lead distal portion 1416 and another example shield 1430, the shield including tapered portions 1432A and 1432B in an expanded configuration. In some examples, shield 1430 and tapered portions 1432A and 1432B are configured to improve transition through a delivery tool lumen during deployment / implantation and improve extraction of distal portion 1416 (and / or medical lead), for example, by providing a smooth shield transition to reduce the shield from getting caught on a catheter and / or sheath when distal portion 1416 is retracted / extracted.
[0129] In some examples, the distal portion 1416 can include one or more markings. In the example shown, the shield 1430 includes markings 1434a and 1434b. In some examples, the markings 1434a and 1434b can be positioned on the shield 1430 and can be configured to indicate the position, orientation, and / or "deformation" or proper deployment of the shield 1430 during or after implantation. For example, the markings 1434a and 1434b can be configured to indicate whether the shield 1430 is improperly deployed, for example, whether at least a portion of the shield 1430 is folded or otherwise improperly deployed, or whether the shield 1430 is properly deployed.
[0130] In some examples, shield 1430 can include a single marker, such as marker 1434c. Marker 1434c can be positioned on shield 1430 and can be configured to indicate the position, orientation, and / or "deformation" or proper deployment of shield 1430 during or after implantation, for example, similar to markers 1434a and 1434b described above, but as a single marker. For example, marker 1434c can have a particular shape and / or symmetry or asymmetry such that marker 1434c is configured to indicate whether shield 1430 is improperly deployed, for example, indicating whether at least a portion of shield 1430 is folded or otherwise improperly deployed, or whether shield 1430 is properly deployed. For example, marker 1434c can have a substantially circular shape that can have an aspect ratio change or deform into an elliptical shape or some other shape if shield 1430 is improperly deployed (e.g., has at least a portion that is folded or not fully inflated). In the example shown, the marker 1434c is a "chevron" or "carrot" shape. In some examples, any or all of the markers 1434a, 1434b, and 1434c can be radiopaque.
[0131] The following embodiments are described herein.
[0132] Embodiment 1: An implantable medical lead comprises: a first defibrillation electrode and a second defibrillation electrode, wherein the first defibrillation electrode and the second defibrillation electrode are configured to deliver a first electrical therapy; a pacing electrode, wherein the pacing electrode is longitudinally disposed between the first defibrillation electrode and the second defibrillation electrode, wherein the pacing electrode is configured to deliver a second electrical therapy comprising a pacing pulse; and a shield, wherein the shield is disposed at least above a portion of an outer surface of the pacing electrode and extends laterally away from the pacing electrode, wherein the shield comprises an asymmetric shape about a longitudinal axis of the shield, wherein the shield is configured to obstruct an electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from the patient's heart.
[0133] Embodiment 2: The implantable medical lead of Embodiment 1, wherein the shield comprises a single layer of substantially planar and biocompatible material.
[0134] Example 3: An implantable medical lead according to Example 1 or Example 2, wherein the longitudinal axis of the shield is along the length of the distal portion of the implantable medical lead including the pacing electrode and the first defibrillation electrode and the second defibrillation electrode, wherein the asymmetric shape of the shield is basically elliptical, and its main axis is substantially aligned with the longitudinal axis of the shield.
[0135] Embodiment 4: The implantable medical lead of Embodiment 3, wherein the asymmetric shape of the shield is a kidney bean shape with a notch on one side of the oval shape.
[0136] Embodiment 5: The implantable medical lead of any one of Embodiments 1 to 4, wherein the shield is configured to self-expand.
[0137] Embodiment 6: The implantable medical lead of Embodiment 5, wherein the shield is configured to be compressed to a first shape for implanting the implantable medical lead and to elastically expand to the asymmetric shape when the implantable medical lead is implanted.
[0138] Embodiment 7: The implantable medical lead according to Embodiment 6, wherein the length of the shield expanded to the asymmetric shape is greater than the length of the pacing electrode, and wherein the width of the shield expanded to the asymmetric shape is greater than the width of the pacing electrode.
[0139] Example 8: An implantable medical lead according to any one of Examples 6 and 7, wherein the distal portion of the implantable medical lead includes the pacing electrode and the first defibrillation electrode and the second defibrillation electrode, wherein the length of the shielding member expanded to the asymmetric shape is greater than the length of the distal portion of the implantable medical lead, and wherein the width of the shielding member expanded to the asymmetric shape is greater than the width of the distal portion of the implantable medical lead.
[0140] Example 9: An implantable medical lead according to Example 8, wherein the distal portion of the implantable medical lead defines a wavy configuration, the wavy configuration including a first peak extending in a first direction, a second peak extending in the first direction, and a third peak extending in a second direction opposite to the first direction between the first peak and the second peak, and wherein at least a portion of the first defibrillation electrode is disposed on the first peak, at least a portion of the second defibrillation electrode is disposed on the second peak, and at least a portion of the pacing electrode is disposed on the third peak.
[0141] Example 10: An implantable medical lead according to Example 9, wherein the distal portion of the implantable medical lead is configured to deform from the wavy configuration to a second configuration, the second configuration being configured to allow the distal portion of the implantable medical lead to be unfolded via a delivery tool and to unfold to the wavy configuration when unfolded, wherein the shielding member is configured to unfold together with the distal portion of the implantable medical lead in the first shape via the delivery tool, and to unfold into the asymmetric shape when unfolded.
[0142] Embodiment 11: An implantable medical lead according to any one of Embodiments 1 to 10, wherein the distal portion of the implantable medical lead includes the pacing electrode and the first defibrillation electrode and the second defibrillation electrode, wherein the shielding member is configured as an elastic membrane mesh bonded to the distal portion along the entire length of the distal portion.
[0143] Embodiment 12: The implantable medical lead of Embodiment 11, wherein the membrane mesh comprises a polyurethane elastomer.
[0144] Embodiment 13: The implantable medical lead of any one of Embodiments 1 to 12, wherein the shield is configured to release from tissue when removed.
[0145] Embodiment 14: The implantable medical lead of any one of Embodiments 1 to 13, wherein the shield extends at least 10 millimeters in any lateral direction from the pacing electrode.
[0146] Embodiment 15: The implantable medical lead of any one of Embodiments 1 to 14, wherein the shield is tapered and bonded to each of the first and second defibrillation electrodes.
[0147] Embodiment 16: The implantable medical lead of any one of Embodiments 1 to 15, wherein the shield is configured to retract into an introducer during removal of the implantable medical lead.
[0148] Embodiment 17: A method, comprising: positioning an implantable medical lead at an implantation location within a patient's body, wherein the implantable medical lead comprises: a first defibrillation electrode and a second defibrillation electrode, the first defibrillation electrode and the second defibrillation electrode being configured to deliver anti-tachyarrhythmia shocks; a pacing electrode, the pacing electrode being longitudinally disposed between the first defibrillation electrode and the second defibrillation electrode, the pacing electrode being configured to deliver pacing pulses that generate an electric field near the pacing electrode; and a shield, the shield being configured to be disposed over at least a portion of an outer surface of the pacing electrode and extending laterally away from the pacing electrode in an expanded configuration, wherein the shield comprises an asymmetric shape around a longitudinal axis of the shield in the expanded configuration, wherein the shield is configured to obstruct an electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from the patient's heart in the expanded configuration; and expanding the shield from a first shape to the asymmetric shape in the expanded configuration via expanding the implantable medical lead.
[0149] Embodiment 18: The method of Embodiment 17, wherein the shield comprises a shape having an atraumatic edge.
[0150] Embodiment 19: The method of Embodiment 17 or 18, wherein the shield comprises a single layer of substantially flat and biocompatible material.
[0151] Example 20: A method according to any one of Examples 17 to 19, wherein the longitudinal axis of the shield is along the length of the distal portion of the implantable medical lead including the pacing electrode and the first defibrillation electrode and the second defibrillation electrode, wherein the asymmetric shape of the shield is substantially elliptical with its major axis substantially aligned with the longitudinal axis of the shield.
[0152] Embodiment 21: The method of Embodiment 20, wherein the asymmetric shape of the shield is a kidney bean shape with a notch on one side of the oval shape.
[0153] Embodiment 22: A method according to any one of Embodiments 17 to 21, wherein the shielding member is configured to be compressed to the first shape in an undeployed configuration, wherein the first shape is configured to be compatible with a delivery tool configured to deploy the implantable medical lead, and wherein the shielding member is configured to elastically self-expand to the asymmetric shape when the implantable medical lead is deployed.
[0154] Embodiment 23: A method according to any one of embodiments 17 to 22, wherein the length of the shield expanded to the asymmetric shape is greater than the length of the pacing electrode, and wherein the width of the shield expanded to the second shape is greater than the width of the pacing electrode.
[0155] Example 24: A method according to any one of Examples 17 to 22, wherein the distal portion of the implantable medical lead includes the pacing electrode and the first defibrillation electrode and the second defibrillation electrode, wherein the length of the shielding member expanded to the asymmetric shape is greater than the length of the distal portion, and wherein the width of the shielding member expanded to the asymmetric shape is greater than the width of the distal portion.
[0156] Embodiment 25: The method of any one of Embodiments 17 to 24, further comprising: removing the implantable medical lead via an introducer, wherein the shield is configured to release from tissue when removed.
[0157] Embodiment 26: The method of Embodiment 25, wherein the shield is tapered and bonded to each of the first and second defibrillation electrodes and is configured to retract into the introducer during removal of the implantable medical lead.
[0158] Embodiment 27: A system comprising: an implantable medical lead, the implantable medical lead comprising: a first defibrillation electrode and a second defibrillation electrode, the first defibrillation electrode and the second defibrillation electrode being configured to deliver a first electrical therapy; a pacing electrode, the pacing electrode being longitudinally disposed between the first defibrillation electrode and the second defibrillation electrode, the pacing electrode being configured to deliver a second electrical therapy comprising a pacing pulse; and a shield, the shield comprising a substantially flat and single-layer biocompatible material, the material being configured to be attached to the implantable medical lead and being in a first shape in an undeployed configuration, wherein the shield is configured to be compatible with a delivery tool in the first shape, wherein the shield is configured to be asymmetrically shaped about a longitudinal axis of the shield and being disposed above a portion of an outer surface of the pacing electrode and extending laterally away from the pacing electrode in a deployed configuration, wherein the asymmetrical shape, wherein the shield is configured to obstruct an electric field of at least one of the first electrical therapy and the second electrical therapy in the deployed configuration in a direction away from the patient's heart.
[0159] Embodiment 28: An implantable medical lead comprises: a first defibrillation electrode and a second defibrillation electrode, wherein the first defibrillation electrode and the second defibrillation electrode are configured to deliver a first electrical therapy; a pacing electrode, wherein the pacing electrode is longitudinally disposed between the first defibrillation electrode and the second defibrillation electrode, wherein the pacing electrode is configured to deliver pacing pulses that generate an electric field near the pacing electrode; and an inflatable shield, wherein the inflatable shield is disposed at least above a portion of an outer surface of the pacing electrode, wherein the inflatable shield is configured to extend laterally away from the pacing electrode when inflated, wherein the inflatable shield is configured to obstruct the electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from the patient's heart.
[0160] Embodiment 29: The medical device system of Embodiment 28, wherein the inflatable barrier is configured to be inflated with at least one of a gas or a liquid.
[0161] Embodiment 30: The implantable medical lead of Embodiment 29, wherein the implantable medical lead comprises a cavity therein, the cavity being coupled to the inflatable shield and configured to provide the gas or the liquid to and from the inflatable shield.
[0162] Embodiment 31: An implantable medical lead according to any one of Embodiments 28 to 30, wherein the length of the inflatable shield when inflated is greater than the length of the pacing electrode, and wherein the width of the inflatable shield when inflated is greater than the width of the pacing electrode.
[0163] Embodiment 32: An implantable medical lead according to any one of Embodiments 28 to 31, wherein the distal portion of the implantable medical lead includes the pacing electrode and the first defibrillation electrode and the second defibrillation electrode, wherein the length of the inflatable shielding member when inflated is greater than the length of the distal portion, and wherein the width of the inflatable shielding member when inflated is greater than the width of the distal portion.
[0164] Embodiment 33: The implantable medical lead of any one of Embodiments 28 to 32, wherein the inflatable shield is electrically insulating.
[0165] Embodiment 34: The implantable medical lead of any of Embodiments 28 to 33, wherein the inflatable shield comprises two layers of polyurethane.
[0166] Example 35: An implantable medical lead according to any one of Examples 28 to 34, wherein the distal portion of the implantable medical lead includes the pacing electrode and the first and second defibrillation electrodes, and wherein the inflatable shield is configured to move the distal portion toward the heart of the patient when inflated.
[0167] Embodiment 36: The implantable medical lead of any one of Embodiments 28 to 35, wherein the pacing electrode is located on the inflatable shield, and the inflatable shield is configured to move the pacing electrode laterally when inflated.
[0168] Embodiment 37: The implantable medical lead of Embodiment 36, wherein the first and second defibrillation electrodes and the pacing electrode are configured to be substantially aligned along a common axis when the inflatable shield is deflated.
[0169] Embodiment 38: The implantable medical lead of any one of Embodiments 28 to 37, wherein the balloon shield is configured to move the pacing electrode backward toward the heart of the patient when expanded from a first shape to a second shape.
[0170] Embodiment 39: A method comprising: positioning an implantable medical lead at an implantation location within a patient's body, wherein the implantable medical lead comprises: a first defibrillation electrode and a second defibrillation electrode, wherein the first defibrillation electrode and the second defibrillation electrode are configured to deliver a first electrical therapy; a pacing electrode, wherein the pacing electrode is longitudinally disposed between the first defibrillation electrode and the second defibrillation electrode, wherein the pacing electrode is configured to deliver pacing pulses that generate an electric field near the pacing electrode; and an inflatable shield, wherein the inflatable shield is disposed at least above a portion of an outer surface of the pacing electrode, wherein the inflatable shield is configured to extend laterally away from the pacing electrode in an inflated shape when inflated, wherein the inflatable shield is configured to obstruct the electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from the patient's heart; and inflating the inflatable shield from a contracted shape to the inflated shape.
[0171] Embodiment 40: The method according to Embodiment 39 further includes inflating the inflatable shielding member using at least one of a gas or a liquid, wherein the implantable medical lead includes a cavity therein, which is coupled to the airbag shielding member and is configured to provide the gas or the liquid to and from the inflatable shielding member.
[0172] Example 41: A method according to Example 39 or Example 40, wherein the length of the inflatable shield when inflated is greater than the length of the pacing electrode, and wherein the width of the inflatable shield when inflated is greater than the width of the pacing electrode.
[0173] Example 42: A method according to any one of Examples 39 to 41, wherein the distal portion of the implantable medical lead includes the pacing electrode and the first defibrillation electrode and the second defibrillation electrode, wherein the length of the inflatable shielding member when inflated is greater than the length of the distal portion, and wherein the width of the inflatable shielding member when inflated is greater than the width of the distal portion.
[0174] Embodiment 43: The method of any one of Embodiments 39 to 42, wherein the inflatable shield is electrically insulating, wherein the inflatable shield comprises two layers of polyurethane.
[0175] Example 44: A method according to any one of Examples 39 to 43, wherein the distal portion of the implantable medical lead includes the pacing electrode and the first defibrillation electrode and the second defibrillation electrode, the method further comprising: moving the distal portion toward the heart of the patient by inflating the inflatable shield.
[0176] Example 45: The method of any one of Examples 39 to 44, further comprising: moving the pacing electrode laterally by inflating the inflatable shield.
[0177] Embodiment 46: The method of any one of Embodiments 39 to 45, wherein the first and second defibrillation electrodes and the pacing electrode are configured to be substantially aligned along a common axis when the inflatable shield is deflated.
[0178] Example 47: The method of any one of Examples 39 to 46, wherein the inflatable shield is configured to move the pacing electrode backward toward the heart of the patient when inflated.
[0179] Embodiment 48: A system comprises: an implantable medical lead, the implantable medical lead comprising: a first defibrillation electrode and a second defibrillation electrode, the first defibrillation electrode and the second defibrillation electrode being configured to deliver a first electrical therapy; a pacing electrode, the pacing electrode being disposed between the first defibrillation electrode and the second defibrillation electrode, the pacing electrode being configured to deliver a second electrical therapy comprising a pacing pulse; and a lead body, the lead body defining a cavity, the cavity being configured to be a guide needle; an inflatable shielding member, the inflatable shielding member being disposed at least over a portion of an outer surface of the pacing electrode, wherein the inflatable shielding member is configured to extend laterally away from the pacing electrode when inflated, wherein the inflatable shielding member is configured to obstruct an electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from the patient's heart; and a diaphragm, the diaphragm being between the cavity and the inflatable shielding member, the diaphragm being configured to form a seal around the needle, wherein the needle is configured to provide at least one of a gas or a liquid to inflate the inflatable shielding member.
[0180] Lead wire and system described herein can be used at least in part in the substernal space, for example, in the anterior mediastinum of the patient, to provide an extravascular ICD system. An implanter (for example, a physician) can use any of a variety of implantation tools, such as a tunnel rod, a sheath or other tools that can pass through the illustrated attachment and form a tunnel in the substernal position, to implant the distal portion of the lead wire in the thorax. For example, an implanter can produce an incision near the center of the patient's trunk, for example, and introduce the implantation tool into the substernal position via the incision. The implantation tool is advanced upward from the incision behind the sternum located in the substernal position. The distal portion of the lead wire is introduced into the tunnel via the implantation tool (for example, via the sheath). When the distal portion is advanced through the substernal tunnel, the distal portion is relatively straight. The preformed or shaped wavy configuration is sufficiently flexible to be straightened when the guide lead wire passes through the sheath or other cavities or passages of the implantation tool. Once the distal portion is in place, the implantation tool is withdrawn toward the incision and removed from the patient's body, while the lead wire is left in place along the substernal path. As the implantation tool is withdrawn, the distal end of the lead assumes its pre-formed wavy configuration and the shield transitions to its expanded configuration.
[0181] In some examples, the distal portion of the lead may be oriented orthogonal to or otherwise transverse to the sternum and / or below the heart, rather than extending in an upward direction along the sternum. In such examples, according to any of the examples described herein, the lead may include one or more shields that cover a portion of the outer surface of one or more electrodes, such as a forward and / or downward portion. One or more such shields may block the electric field in a direction away from the heart, which may be a forward and / or downward direction.
[0182] It should be understood by those skilled in the art that the present application is not limited to the contents specifically shown and described above. In addition, unless otherwise indicated above, it should be noted that all drawings are not drawn to scale. Without departing from the scope and spirit of the present application, various modifications and variations are possible according to the above teachings, and the scope and spirit of the present application are limited only by the appended claims.
Claims
1. An implantable medical lead, the implantable medical lead include: a first defibrillation electrode and a second defibrillation electrode, the first defibrillation electrode and the second defibrillation electrode configured to deliver a first electrical therapy; a pacing electrode disposed longitudinally between the first defibrillation electrode and the second defibrillation electrode, the pacing electrode configured to deliver pacing pulses that generate an electric field proximate the pacing electrode; and an inflatable shield disposed over at least a portion of an outer surface of the pacing electrode, wherein the inflatable shield is configured to extend laterally away from the pacing electrode when inflated, wherein the inflatable shield is configured to obstruct an electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from the patient's heart.
2. The medical device system of claim 1, wherein the inflatable barrier is configured to be inflated with at least one of a gas or a liquid.
3. The implantable medical lead of claim 2, wherein the implantable medical lead comprises a cavity therein, the cavity being coupled to the inflatable shield and configured to provide the gas or the liquid to and from the inflatable shield.
4. The implantable medical lead according to any one of claims 1 to 3, wherein the length of the inflatable shield when inflated is greater than the length of the pacing electrode, and wherein the width of the inflatable shield when inflated is greater than the width of the pacing electrode.
5. The implantable medical lead of any one of claims 1 to 4, wherein a distal portion of the implantable medical lead comprises the pacing electrode and the first and second defibrillation electrodes, wherein a length of the inflatable shield when inflated is greater than a length of the distal portion, and wherein a width of the inflatable shield when inflated is greater than a width of the distal portion.
6. The implantable medical lead of any one of claims 1 to 5, wherein the inflatable shield is electrically insulating.
7. The implantable medical lead of any one of claims 1 to 6, wherein the inflatable shield comprises two layers of polyurethane.
8. An implantable medical lead according to any one of claims 1 to 7, wherein a distal portion of the implantable medical lead includes the pacing electrode and the first and second defibrillation electrodes, wherein the inflatable shield is configured to move the distal portion toward the heart of the patient when inflated.
9. The implantable medical lead of any one of claims 1 to 8, wherein the pacing electrode is located on the inflatable shield, and the inflatable shield is configured to move the pacing electrode laterally when inflated.
10. The implantable medical lead of Claim 9, wherein the first and second defibrillation electrodes and the pacing electrode are configured to be substantially aligned along a common axis when the inflatable shield is deflated.
11. The implantable medical lead of any one of claims 1 to 10, wherein the balloon shield is configured to move the pacing electrode backward toward the heart of the patient when expanded from a first shape to a second shape.
12. A system, wherein the system include: An implantable medical lead, comprising: A first defibrillation electrode and a second defibrillation electrode, wherein the first defibrillation electrode and the a second defibrillation electrode configured to deliver a first electrical therapy; a pacing electrode disposed between the first defibrillation electrode and the second defibrillation electrode, the pacing electrode configured to deliver a second electrical therapy comprising pacing pulses; and a lead body defining a lumen configured as a guide needle; an inflatable shield disposed over at least a portion of an outer surface of the pacing electrode, wherein the inflatable shield is configured to extend laterally away from the pacing electrode when inflated, wherein the inflatable shield is configured to obstruct an electric field of at least one of the first electrical therapy and the second electrical therapy in a direction away from a heart of the patient; and A diaphragm is between the cavity and the inflatable barrier, the diaphragm being configured to form a seal around the needle, wherein the needle is configured to provide at least one of a gas or a liquid to inflate the inflatable barrier.
